FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents a method of treating psoriasis or a related symptoms, in an individual, involving the local administration of a local composition containing a therapeutic effective amount of an α2 adrenergic receptor agonist and a pharmaceutically acceptable carrier on an individual's skin area, wherein the skin area is subject to psoriasis or the related symptom, or prone thereto, and wherein the α2 adrenergic receptor agonist is brimonidine.
EFFECT: invention provides developing the effective and safe method for treating or preventing psoriasis with no side effects or small side effects.
10 cl, 1 tbl, 2 ex
